Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

@article{Snchez2004ComparisonOT,
  title={Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding},
  author={Connie S{\'a}nchez and John Hyttel},
  journal={Cellular and Molecular Neurobiology},
  year={2004},
  volume={19},
  pages={467-489}
}
Abstract1. The present survey compares the effects of antidepressants and their principal metabolites on reuptake of biogenic amines and on receptor binding. The following antidepressants were included in the study: the tricyclic antidepressants amitriptyline, dothiepin, and lofepramine and the atypical antidepressant bupropion, which all have considerable market shares in the UK and/or US markets; the selective serotonin reuptake inhibitors (SSRIs) citalopram, fluoxetine, fluvoxamine… Expand
Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin4 Receptor Agonists in the Rat
TLDR
In acute conditions, the 5-HT4 agonist prucalopride was able to counteract the inhibitory effect of the selective serotonin reuptake inhibitors (SSRI) fluvoxamine and citalopram on 5- HT neuron impulse flow, in Dorsal Raphé Nucleus cells selected for their high basal discharge. Expand
Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex
TLDR
Results do not support the hypothesis that compared to SSRIs, compounds which inhibit both 5-HT and noradrenaline reuptake have a larger acute effect on extracellular 5- HT, and the effects of acute systemic administration of several SNRIs andSSRIs are compared. Expand
Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?
  • D. Wong, F. Bymaster
  • Medicine
  • Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
  • 2002
TLDR
Comparative trials of dual uptake inhibitors against the other agents are needed to establish whether the dual uptake inhibitor show improvement in efficacy, rate of responders, antidepressive effects and/or remission. Expand
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
  • P. Gillman
  • Medicine, Chemistry
  • British journal of pharmacology
  • 2007
New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their cytochrome P450 enzyme inhibition profiles, allow improved deductionsExpand
Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.
TLDR
Two different mechanisms of the antidepressant-CYP2B interaction are postulated: a direct inhibition of CYP2B shown in vitro by nefazodone, SSRIs and TADs and in vivo induction of CYp2B produced by prolonged administration of SSR Is and desipramine, which suggests their influence on enzyme regulation. Expand
Tolerability and safety of fluvoxamine and other antidepressants
TLDR
Although the literature suggests that there are no clinically significant differences in efficacy amongst SSRIs, treatment decisions need to be based on considerations such as patient acceptability, response history and toxicity. Expand
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview
TLDR
Primary properties of the SSRIs may contribute to the differences in efficacy and tolerability between members of the class, and for example, fluvoxamine has affinity for σ1‐receptors – a property likely to be responsible for its particular efficacy in delusional depression. Expand
Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?
Summary Most antidepressant drugs act not only on molecular targets directly responsible for their expected therapeutic action (monoamine transporters, monoamine oxidase A, presynaptic inhibitoryExpand
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms
TLDR
It is shown that the metabolite des methylcitalopram accumulates in the brain and that the metabolites desmethylcitalsertraline, norfluoxetine, and desvenlafaxine inhibit serotonin uptake in wild-type mSERT at potencies similar to those of their parent compounds, suggesting that metabolites may play a role in effects observed following AD administration inWild-type and M172 mice. Expand
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors
TLDR
A crucial role played by the 5- HT1A receptors is suggested in balancing the reuptake inhibitory efficacy for the enhancement of 5-HT and DA transmission in the PFC by the drugs combining the reptake inhibition of all three monoamines. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
TLDR
Evidence is provided that fluoxETine, norfluoxetine and citalopram, along with many other antidepressant compounds, interact directly with the 5-HT2C receptor. Expand
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
  • J. Hyttel
  • Biology, Medicine
  • International clinical psychopharmacology
  • 1994
TLDR
Since the marketed SSRIs all show clear antidepressant effect, this receptor regulation seems not to be a prerequisite for clinical antidepressant activity. Expand
Comparison of the Effects of Sertraline and Its Metabolite Desmethylsertraline on Blockade of Central 5-HT Reuptake In Vivo
TLDR
The data suggest that DMS does not contribute to the blockade of central 5-HT reuptake produced by sertraline in vivo and therefore would be expected to play a negligible role in its clinical activity. Expand
Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity
  • J. Hyttel
  • Medicine, Chemistry
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1982
TLDR
Citalopram has no antagonistic activity towards DA, NA, 5-HT, histamine, gamma aminobutyric acid (GABA), acetylcholine, and morphine receptors, which makes it a most promising antidepressant drug. Expand
Comparative pharmacology of dothiepin, its metabolites, and other antidepressant drugs
The pharmacology of dothiepin and its human metabolites, northiaden, dothiepin sulfoxide, and northiaden sulfoxide, has been studied to determine whether the latter contribute to the therapeutic orExpand
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
TLDR
The enantiomers of norfluoxetine have markedly different potencies as inhibitors of the uptake of serotonin, based on their antagonism of p-chloroamphetamine-induced depletion of serotonin in brain and their lowering of concentrations of the metabolite of serotonin. Expand
Pharmacokinetic Optimisation of Therapy with Newer Antidepressants
  • P. Goodnick
  • Chemistry, Medicine
  • Clinical pharmacokinetics
  • 1994
TLDR
The antidepressants best suited for pharmacokinetic optimisation of therapy are the following: desipramine, sertraline, fluvoxamine, citalopram and amfebutamone, which stands out as having the best effects on behaviour among all antidepressants. Expand
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
TLDR
The treatment of patients with major depression using an SSRI and pindolol, a 5-HT1A/ beta-adrenoceptor antagonist, markedly reduced the latency of the antidepressant response in previously untreated patients and induced a rapid improvement in treatment-resistant patients. Expand
Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
TLDR
Imipramine-induced down-regulation of 5- HT2 receptors may not involve presynaptic 5-HT mechanisms, and imipramines-induced alterations in 5,7-DHT2 sensitivity as reflected in the quipazine-induced head shake may, in part, be influenced by beta-adrenergic receptors. Expand
Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone
TLDR
The similar reduction in the Bmax values of 3H-ketanserin binding following chronic treatment with the rapidly Dissociating setoperone and the slowly dissociating ritanserin suggest that real serotonin-S2 receptor down regulation occurs following antagonist treatment. Expand
...
1
2
3
4
5
...